SCARLETRED: Patents granted in Japan and Australia

IP Protection for Scarletred®Vision in the EU, USA, Japan and Australia.

After obtaining patent approval for the product Scarletred®Vision in the EU and in USA, IP protection has been expanded also to Japan and Australia. 

SCARLETRED's granted method patent covers a broad set of technology claims for objective and quantitative documentation and analysis of changes in skin color and in particular for assessing erythema with a current total skin market of 1.35 billion people.

Specially remote areas in Australia are targeted by SCARLETRED's novel upcoming Tele-Dermatology services, whereas Japan reflects a promising future market for novel cosmetics B2C applications.

Read more.